End of the line. All change

Over the past two years, much regulatory attention has been focused on the way conflicts of interest affect the production of investment research and the issuance of capital market debt. Although driven by the high-profile cases in the United States, this has become a matter of international regulatory concern.

In response to this crisis of confidence in sell-side research, the UK’s Financial Services Authority (FSA) last month released its response to February’s consultation paper

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here